The international group of experts, including Professor John Bridgewater (UCL Cancer Institute), is calling for rapid ...
The international group of experts, including Professor John Bridgewater (UCL Cancer Institute), is calling for rapid improvements in diagnosis, treatment and research for cholangiocarcinoma, also ...
Please provide your email address to receive an email when new articles are posted on . The FDA granted accelerated approval to zanidatamab-hrii for treatment of adults with previously treated ...
Dr. Shaun P. McKenzie discusses bile duct cancer challenges and why awareness and specialized care help patients get ...
Hosted on MSN
Bile duct cancer: These changes occur in the body at the onset of bile duct cancer; early diagnosis can save lives
Cancer is a disease that can be treated more effectively if diagnosed early. However, some types of cancer have mild early symptoms and mimic common health problems. Therefore, the disease is often ...
Zanidatamab-hrii received FDA accelerated approval for HER2-positive biliary tract cancer, showing a 52% objective response rate in the HERIZON-BTC-01 trial. Biliary tract cancers represent 3% of ...
Bile duct cancer is classified by location: intrahepatic, perihilar, or distal, influencing symptoms and treatment options. Diagnosis involves blood tests, imaging, endoscopic procedures, and biopsy ...
The PATHWAY HER2 (4B5) test helps to identify patients with previously-treated, unresectable or metastatic HER2-positive biliary tract cancer (BTC) who may be eligible for treatment with ZIIHERA.
Hosted on MSN
I didn't have any symptoms… Hard-to-detect bile duct cancer, only 30% of surgery is possible
The bile duct is a pathway in which bile produced in the liver travels through the gallbladder to the duodenum, and a malignant tumor in the bile duct is called 'bile duct cancer'. Bile duct cancer is ...
Rachna Shroff, MD, is the associate director of clinical investigations at the U of A Cancer Center and a professor and chief of the division of hematology and oncology at the College of Medicine – ...
Biliary tract cancers, including intrahepatic, perihilar, and extrahepatic cholangiocarcinoma and gallbladder cancer, are among the most aggressive gastrointestinal malignancies. Treatment options ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results